EX-99.2 5 ex_598322.htm EXHIBIT 99.2 ex_598322.htm

Exhibit 99.2

 

  VOTE ON INTERNET
  Go to http://www.Vstocktransfer.com/proxy
  Click on Proxy Voter Login and log-on using the below control number. Voting will be open until 11:59 p.m. Eastern Time on December 25, 2023.
  CONTROL # VOTE BY EMAIL
  Mark, sign and date your proxy card and return it to vote@Vstocktransfer.com
* SPECIMEN *  
1 MAIN STREET VOTE BY MAIL
ANYWHERE PA 99999-9999 Mark, sign and date your proxy card and return it in the envelope we have provided.
  VOTE IN PERSON
  If you would like to vote in person, please attend the Special Meeting to be held on December 26, 2023 at 10:00 a.m. Eastern Time at the offices of Fox Rothschild LLP, located at 101 Park Avenue, 17th Floor, New York, New York 10178.

 

 

 

 

Please Vote, Sign, Date and Return Promptly in the Enclosed Envelope.

 

Special Meeting of Stockholders Proxy Card - Cyclo Therapeutics, Inc.

 

ex_585910img001.jpg DETACH PROXY CARD HERE TO VOTE BY MAIL ex_585910img001.jpg

THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS A VOTE "FOR" ALL LISTED PROPOSALS.

 

1.

To approve an amendment to our Articles of Incorporation, as amended, increasing the number of authorized shares of our common stock from 50,000,000 shares to 250,000,000 shares.

  FOR AGAINST ABSTAIN  

2.

To approve, in accordance with the Nasdaq listing rules, the issuance of shares of our common stock to stockholders of Applied Molecular Transport Inc. pursuant to the Agreement and Plan of Merger, dated September 21, 2023, among Cyclo Therapeutics, Inc., Cameo Merger Sub, Inc., a Delaware corporation and a direct wholly owned subsidiary of Cyclo Therapeutics, Inc., and Applied Molecular Transport Inc., as may be amended from time to time.

FOR AGAINST ABSTAIN

3.

To approve the adjournment from time to time of the Special Meeting, if necessary, to solicit additional proxies if there are insufficient shares of our common stock present or represented by proxy at the Special Meeting to constitute a quorum at the Special Meeting or any adjournment or postponement thereof.

FOR AGAINST ABSTAIN

 

Date   Signature   Signature, if held jointly  
           

Note: This proxy must be signed exactly as the name appears hereon. When shares are held jointly, each holder should sign. When signing as executor, administrator, attorney, trustee or guardian, please give full title as such. If the signer is a corporation, please sign full corporate name by a duly authorized officer, giving full title as such. If signer is a partnership, please sign in partnership name by an authorized person.

To change the address on your account, please check the box at right and indicate your new address.         ex_585910img012.jpg

* SPECIMEN * AC:ACCT9999 90.00

 

 

 

 

CYCLO THERAPEUTICS, INC.

Special Meeting of Stockholders December 26, 2023

 

 

 

 

ex_585910img013.jpg DETACH PROXY CARD HERE TO VOTE BY MAIL ex_585910img014.jpg

 

THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS

 

The undersigned, revoking all prior proxies, hereby appoints N. Scott Fine and Jeffrey L. Tate and each of them, with full power of substitution, as proxy to represent and vote all shares of common stock, par value $0.0001 per share, of CYCLO THERAPEUTICS, INC. (the “Company,” “we,” “our,” and “us”) in connection with the solicitation of proxies by the Board of Directors of the Company (the “Board of Directors” or the “Board”) to be used at the Special Meeting of Stockholders (the “Special Meeting”) to be held on December 26, 2023 at 10:00 a.m. (Eastern Time) and at any postponement of adjournment thereof. The Special Meeting will be held at Fox Rothschild LLP, 101 Park Avenue, 17th Floor, New York, New York 10178.

 

This proxy, when properly executed, will be voted as directed. If no direction is made, the proxy shall be voted “FOR” each listed proposal.

 

Please check here if you plan to attend the Special Meeting of Stockholders on December 26, 2023 at 10:00 a.m. (ET ). ex_585910img015.jpg

 

PLEASE BE SURE TO SIGN REVERSE SIDE OR PROXY WILL NOT BE VALID

 

TEST ISSUE REF 1999